Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
LGBTQ+ Cancer Symposium aims to increase visibility of patients of all genders and sexualities

LGBTQ+ Cancer Symposium aims to increase visibility of patients of all genders and sexualities

Although there are more than 11 million LGBTQ+-identifying individuals in the U.S., this population remains “invisible in the research”—presenting a problem for cancer centers trying to better serve their catchment areas, said Zul Surani, associate director of community outreach and engagement at Cedars-Sinai Cancer.
April 29, 2022
Vol.48 No.17
By Alice Tracey
Fly the pride flag—and free the LGBTQ+ community from the oppression of smoking
FreeGuest Editorial

Fly the pride flag—and free the LGBTQ+ community from the oppression of smoking

Pride month is upon us, and the rainbow flag is flying high. At levels that would have been unimaginable a few decades ago, corporate sponsors acknowledge and celebrate the right of LGBTQ+ individuals to live free of violence, discrimination, and oppression. 
June 25, 2021
Vol.47 No.25
By Phoenix A. Matthews
In Brief

Moffitt Cancer Center study educates oncologists on LGBTQ+ health concerns

Moffitt Cancer Center is launching a nationwide study to help educate oncologists and address health care disparities among LGBTQ+ patients.
September 25, 2020
Vol.46 No.36

Posts navigation

Previous12

Trending Stories

  • With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shutdown
  • Anthony G. Letai to be named NCI director
    The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say
  • Anthony Letai sworn in as 18th NCI director
  • Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research
  • Population-based cancer surveillance is a national treasure at risk
  • Former NCI official’s nonprofit seeks to tell the stories of cancer patients
    Patient Action for Cancer Research aims to show impact of federal research

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2025 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account